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Abstract
Background: Patients who underwent a successful repair of the aortic coarctation (CoA) show high risk for
cardiovascular (CV) events. Mechanical and structural abnormalities in the ascending aorta (Ao) might have a
role in the prognosis of CoA patients. We analyzed the elastic properties of Ao measured as aortic stiffness
index (AoSI) in CoA patients in the long-term period and we compared AoSI with a cohort of 38 patients with
rheumatoid arthritis (RA) and 38 non-RA matched controls.
Methods: Data from 19 CoA patients were analyzed 28 ± 13 years after surgery. Abnormally high AoSI was
diagnosed if AoSI > 6.07% (95th percentile of the AoSI detected in our reference healthy population). AoSI was
assessed at the level of the aortic root by two-dimensional guided M-mode evaluation.
Results: CoA patients showed more than two-fold higher AoSI compared to RA and controls (9.8 ± 12.6 vs 4.8 ± 2.5%
and 3.1 ± 2.0%, respectively; all p < 0.05 and in 5 of 19 patients with CoA (26%) AoSI was exceptionally high. The 5
patients with abnormally high AoSI were older with higher BP, LV mass and prevalence of LV diastolic dysfunction.
Multiple linear regression analysis revealed that AoSI was independently related to the presence of LV hypertrophy and
higher LV relative wall thickness.
Conclusions: CoA patients have higher AoSI levels than RA patients and non-RA matched controls. AoSI levels are
abnormally high in a small sub-group of CoA patients who show a very high-risk clinical profile for adverse CV events.
Background
Despite successfully treated, patients with repaired aortic
coarctation (CoA) have reduced long-term survival
compared with an age and sex matched population [1].
The presence of high systemic blood pressure generally
found in these patients together with altered integrity
of the aorta due to surgical repair, and/or acquired
post-surgery, cause progressive change in the structure and
function of arterial vessels [2–4]. Therefore, it is common
to find hypertrophy and hyperplasia of smooth muscle
cells, together with modification of the matrix protein [5].
The continuous deposition of a variety of proteins,
including collagen, combined with the progressive loss of
the elastic matrix leads to a further increase in arterial stiff-
ness and reduction of vascular compliance [6]. Similar fea-
tures have been found in patients affected by rheumatoid
arthritis (RA) which represents a clinical model of acquired
extensive arterial disease with abnormal vascular responses
[7] to inflammation and/or damaging molecular modula-
tors of immune system. Abnormal aortic elastic properties
are associated with older age and higher blood pressure in
RA patients [8]. The result of these changes is stiffening of
the arteries and consequent increase of aortic stiffness
index (AoSI) which is used to evaluate arterial stiffness and
it is an independent predictor of cardiovascular morbidity
and mortality [9]. AoSI showed a strong correlation with
the invasive measurements of arterial stiffness and more
popular non-invasive techniques such as pulse wave
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velocity or Tissue Doppler [10–13]. Accordingly, in this
study we measured the AoSI of the ascending aorta in
patients with successful CoA repair in the long-term
period and we compared it with a cohort of RA patients.
Methods
Study population
The study population consisted of 19 non-institutionalized
subjects > 18 years of age who consecutively underwent
successful repair of CoA during the period from 1964 to
2010 and were subsequently followed-up by the Institute
for Maternal and Child Health-IRCCS, Burlo Garofolo and
at the Cardiovascular (CV) Center, Maggiore Hospital,
Trieste, Italy. Repair of CoA was obtained by: end-to end
anastomosis in 9 patients, patch in 4 patients, subclavian
flap in 2 patients, subclavian artery flap in 1 patient and
percutaneous stent in 3 patients. The mean duration of
follow-up was 28 ± 13 years. The patients’ inclusion criteria
were:
– Residual isthmic gradient by echo-Doppler less than
20 mm Hg;
– Aortic diameter at the site of repair/diaphragmatic
aorta ratio more than 0.7 at cardiac MRI
– No associated cardiac abnormalities or moderate/
severe valve heart disease;
– No bicuspid aortic valve with moderate/severe
regurgitation or stenosis;
– Absence of history of myocardial infarction or prior
myocardial revascularization, asymptomatic known
LV dysfunction, heart failure, primary
cardiomyopathies or myocarditis, atrial fibrillation,
chronic kidney disease, obstructive sleep apnea
syndrome, RA (all conditions eliciting changes in LV
geometry and LV systolic dysfunction). All patients
underwent transthoracic echocardiogram, clinical
and laboratory evaluation at the CV Center,
Maggiore Hospital, Trieste, Italy. Patients expressed
their general written consent to the anonymous use
of data for their care and research purposes. The
study complies with the Declaration of Helsinki as
revised in 2000; the locally appointed ethic
committee has approved the research protocol.
Rheumatoid arthritis group
A group of 38 patients matched for age, sex, blood pressure,
history of hypertension and affected by RA was identified.
RA was diagnosed by clinical and laboratory examination
according to the American College of Rheumatology cri-
teria [14]. They were selected by a large cohort of patients
consecutively recruited from January 2014 to December
2014 in three Italian referral centers (Verona, Trieste,
Trento) with fully accessible cardiac units provided in
which patients underwent echocardiographic, clinical
and laboratory evaluations.
Control group
A control group of 38 subject defined “non-RA patients”
matched for age, sex, blood pressure and history of
hypertension was identified. RA patients and non-RA
controls were studied for the reason to assess the range
of values of aortic stiffness in a model of abnormal
vascular responses and of acquired chronic arterial disease,
respectively. Controls were free of symptoms/signs of
cardiac disease and had no history of myocardial illness or
valve heart disease, including evidence of more than mild
mitral annular calcification at echocardiographic baseline
evaluation. These two groups of subjects were statistically
comparable with those enrolled into the study for age, sex,
blood pressure and hypertension according to the follow-
ing procedure: a Gower’s generalized distance from each of
the RA individual and each CoA patient was computed
and all patients were ranked in ascending order in the
database. The distance was calculated using these variables
ordered as follows: age, gender, systolic blood pressure and
hypertension. The 38 RA patients and 19 CoA patients
were then demarcated and coupled by taking for everyone
patient with CoA the two closest controls (selected by a
pool of 250 patients). Then, the 19 patients with CoA were
compared with a second control group (defined non-RA
matched controls), composed of 38 patients, matched for
age, sex, blood pressure and prevalence of hypertension by
the same statistical procedure described above. The 38
non-RA matched controls were designated by taking for
everyone close patient with CoA the two closest control.
These subjects were selected by a pool of 180 patients who
consecutively performed at our Center a clinical and an
echocardiographic evaluation for a CV risk assessment in
primary prevention.
Definitions
Arterial hypertension was defined as systolic blood pres-
sure of ≥140 mmHg and/or a diastolic blood pressure of
≥90 mmHg and/or pharmacologically treated high blood
pressure. Obesity was diagnosed if patients had body
mass index ≥30 kg/m2. Dyslipidemia was defined as
levels of total serum cholesterol > 190 mg/dl and or
triglycerides > 150 mg/dl or pharmacologically treated
high lipid serum levels.
Echocardiography
LV chamber dimensions and wall thicknesses were
measured by the American Society of Echocardiography
guidelines and LV mass calculated using a necropsy
validated formula [15]. LV mass was normalized for height
to the 2.7 power and LV hypertrophy was defined as LV
mass > 49.2 g/m2.7 for men and > 46.7 for women [16].
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Relative wall thickness was calculated as the 2 * end-dia-
stolic ratio posterior wall thickness/LV diameter and indi-
cated concentric LV geometry if > 0.43 (the 97.5
percentile in normal population) [17] LV end-diastolic
and end-systolic volumes were measured by the biplane
method of disks from 2D apical 4 chamber + 2 chamber
views and used to calculate ejection fraction, defined as
index of global LV systolic function measured at endo-
cardium. LV ejection fraction < 50% was indicative of
LV systolic dysfunction (LVSD). LV systolic function
was also assessed by measuring the systolic shortening
of the LV minor axis at the midwall level to specifically
evaluate the circumferential component of LV systolic
function. Midwall shortening was calculated considering
the epicardial migration of the midwall during systole
caused by the architectural organization of myocardial
fibers, as previously described [18]. Midwall end-systolic
circumferential stress (sc-MS) was calculated and related
to midwall shortening to assess afterload-independent
LV systolic function [19]. Thus, sc-MS refers to the
ratio observed/predicted midwall shortening for a given
end-systolic circumferential stress and corrects for this
variable the LV systolic function. sc-MS < 89% (10th
percentile of our healthy controls) was indicative of
circumferential LVSD. Furthermore, Tissue Doppler study
(pulsed wave spectral analysis) was used to measure peak
mitral annular systolic velocity (peak S’, mean of 4 measure-
ments obtained in septal, lateral, inferior and anterior mitral
annular position), as an estimate of longitudinal component
of LV systolic function [20]. Peak S’ < 8.5 cm/sec (10th
percentile of our healthy controls) indicated longitudinal
LVSD. Transmitral and pulmonary vein pulsed wave
Doppler curves and early diastolic Tissue Doppler velocity
of mitral annulus (E’) were assessed according to the
recommendations of the American Society of Echocardi-
ography [21]. Early diastolic velocity of transmitral flow
(E) was divided by E’ and used to classify LV diastolic
function together with other parameters (E/A ratio of
transmitral flow, deceleration time of E and the difference
in duration of atrial wave on pulmonary vein flow and
atrial wave on transmitral flow) in 4 degrees as proposed
by Redfield et al. [22]: normal, mild dysfunction, moderate
dysfunction and severe dysfunction. LV end-diastolic
pressure was non-invasively estimated by the equation
validated by Ommen et al. [23]. Maximal left atrial volume
was also computed from 2D apical 4-chamber view using
the area - length method and was normalized for body
surface area. The residual isthmic gradient was assessed
with a standalone, 2.0-MHz, continuous-wave Doppler
probe using the modified Bernoulli equation: gradient
(mmHg) = 4(V2
2 - V1
2) m/s, where V2 was the maximum
velocity in the descending aorta and V1 was the velocity in
the descending aorta above the coarctation site when a
double shadow could be obtained on Doppler tracing, or
V1 was the velocity in the ascending aorta when a suitable
tracing was not obtained [24]. Doppler gradients were
considered as the mean of at least 3 consecutive
measurements.
Calculation of aortic stiffness
Aortic stiffness was assessed at the level of the aortic root,
using a two-dimensional guided M-mode evaluation of
systolic (AoS) and diastolic (AoD) aortic diameters, 3 cm
above the aortic valve together with blood pressure
measured by cuff sphygmomanometer. AoD was obtained
at the peak of the R wave at the simultaneously recorded
electrocardiogram, while AoS was measured at the
maximal anterior motion of the aortic wall [25]. For
each diameter five measurements were averaged. The
following formula was used for assessing aortic stiffness
index (AoSI):
AoSIð Þ %ð Þ ¼ ln SBP=DBPð Þ= AoS AoDð Þ=AoD½ 
where ln[systolic blood pressure (SBP)/diastolic blood
pressure (DBP)] refers to the natural logarithm of the
relative blood pressure (SBP and DBP: systolic and diastolic
blood pressure) [26]. Blood pressure was measured at the
end of echocardiographic evaluation in supine position.
AoD and AoS were evaluated off-line by the principal
investigator blinded to the identity of the subject.
Reproducibility data on AoSI assessment have been
previously reported [27].
Cardiac magnetic resonance
The degree of residual coarctation was determined by
spin-echo magnetic resonance imaging of the thoracic
aorta. The smallest diameter was measured by hand calipers
from internal edge to internal edge of the vascular walls
from a combination of 2 views: transverse and sagittal
oblique (left anterior oblique equivalent) through the center
of the vessel. The smallest diameter was compared with the
diameter of the aorta at the diaphragm. Percent narrowing
was calculated as: % narrowing = 100 (1 - smallest
diameter/diameter at diaphragmatic level).
Statistical analysis
Categorical variables are presented as percentages, while
continuous variables are presented as their means and SD.
Categorical variables were compared by the chi-square
test and continuous variables by the t-test or the Mann–
Whitney U-test. The study population was also stratified
by status of abnormally high AoSI at baseline. The cut-off
value for abnormally high AoSI was a priori identified as
6.07% (the 95th percentile of AoSI calculated in the 113
healthy subjects) as previously reported. Multiple linear
regression analysis was computed to assess the variables
significantly related to AoSI index in CoA patients.
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Variables significantly related to AoSI in univariate
tests (p < 0.01) were considered in the multivariable
model, which included age, body mass index, systolic
blood pressure, E/E’, LV relative wall thickness and LV
hypertrophy. All analyses were performed using statistical
package SPSS 19.0 (SPSS Inc. Chicago. Illinois) and statis-
tical significance was identified by two-tailed p < 0.05.
Results
Study population
All subjects were free of symptoms and clinical signs of
cardiac disease at the time of clinical, laboratory and
echocardiographic evaluation. During the 28 ± 13 years
of follow-up after surgical intervention, no patient who had
undergone successful repair of CoA suffered from an
adverse CV event either was hospitalized for any sign or
symptoms potentially related to the presence of CV disease.
Similarly, RA and non-RA matched controls were analyzed
in primary prevention. Clinical and echocardiographic
characteristics of the study population compared with
RA patients (mean time from the RA diagnosis 14 ±
10 years) and non-RA matched controls are shown in
Tables 1 and 2, respectively. Between all groups, there
were no statistical differences in terms of age, sex, body
mass index, laboratory data and prevalence of dyslipidemia,
type 2 diabetes mellitus and blood hypertension. Despite
RA subjects were taking less anti-hypertensive medications
compared to CoA patients and controls, blood pressure
values were similar between the groups. All groups had
LV dimensions within the normal range, however CoA
patients showed higher prevalence of LV hypertrophy
than controls and RA patients (37% vs 20% vs. 6%,
respectively; all p < 0.05) associated with a higher end-
systolic circumferential stress and lower relative wall
thickness, index of concentric LV geometry. Regarding
to the parameters of LV systolic function, all three
groups showed similar LV ejection fraction and sc-MS
(parameter of LV circumferential systolic function),
however peak S’ (parameter of longitudinal LV systolic
function), was significantly lower in CoA subjects than
Table 1 Main clinical characteristics of the 19 study patients with aortic coarctation compared with 38 controls matched for
cardiovascular risk factors and 38 patients with rheumatoid arthritis
Variables Aortic coarctation (19 patients) Controls (38 patients) RA (38 patients)
Clinical
Age (years) 33 ± 12 35 ± 14 37 ± 6
Female gender (%) 37 32 48
Body mass index (Kg/m2) 23.9 ± 4.0 26.8 ± 4.4 24.2 ± 4.2
Obesity (%) 11 17 9
Hypertension (%) 58 65 41
Dyslipidemia (%) 5 5 15
Active smoker (%) 21 12 28
Diabetes (%) 5 5 3
Systolic blood pressure (mmHg) 127 ± 17 131 ± 19 125 ± 16
Diastolic blood pressure (mmHg) 77 ± 9 83 ± 10 82 ± 10
Heart rate (beats/minute) 68 ± 12 71 ± 14 76 ± 10
Laboratory
Glycemia (mg/dl) 93 ± 9 98 ± 10 93 ± 9
Hemoglobin (gr/dl) 13.8 ± 1.6 14.6 ± 1.7 14.0 ± 1.2
GFR (ml/min/1.73m2) 105 ± 26 103 ± 20 108 ± 26
Pharmacological treatment
Betablockers (%) 32 22 8 # §
ACEi / ARB (%) 32 52 12 # §
Diuretics (%) 16 30 3 # §
Calcium antagonists (%) 11 35 3 # §
Anti-platelets agents (%) 0 1 4
Statins (%) 0 1 1
ACEi Angiotensin-converting enzyme inhibitors, ARB Angiotensin T1 receptor blockers, GFR Glomerular Filtration Rate, RA rheumatoir arthritis
# = p < 0.05 rheumatoid arthritis (RA) vs coarctation
§ = p < 0.05 RA vs controls
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controls and RA patients (7.1 ± 1.3 vs. 10.5 ± 3.6 vs.
10.2 ± 1.6 cm/sec; p < 0.05). CoA patients had a greater
prevalence of LV diastolic dysfunction as shown by
raised E/E’ ratio and end-diastolic pressure.
Aortic arterial stiffness
AoSI was significantly higher in the CoA group compared
to RA subjects (9.8 ± 12.6% vs. 4.8 ± 2.5%, p < 0.0001) and
in turn, RA subjects had increased values compared to
non-RA matched controls (4.8 ± 2.5% vs. 3.1 ± 2.0, p = 0.02)
(Fig. 1). The marked increase in AoSI found in CoA
patients was essentially due to the presence of 5 subjects
showing abnormally high AoSI (mean value 28.9 ± 6.5%)
in comparison of the remaining 14 who had AoSI values
in the normal range (2.5 ± 1.9%) (Fig. 2). The clinical and
echocardiographic characteristics of CoA patients with
and without abnormally high AoSI are shown in Table 3.
Among CoA group, patients who had abnormally high
AoSI were older, with higher blood pressure values, body
mass index, LV mass and worse diastolic function. Four
out of five patients were treated with end-to-end anas-
tomosis and only in one case a dacron-patch was used.
Multiple linear regression analysis revealed that AoSI
was independently related to LV hypertrophy and higher
LV relative wall thickness, index of concentric LV geometry
(Table 4). Considering the control group, abnormally high
AoSI was detected in 4 of 38 (10%) and in 5 of 38 patients
with RA (21%). Among the three groups there were no
statistically significant differences in the size of the
aortic root.
Discussion
In our study, we analyzed AoSI after three decades of
follow up in patients who underwent successful CoA
repair and we compared it with two different cohorts of
patients: the first one, non-RA patients matched for
Table 2 Echocardiographic characteristics
Variables Aortic coarctation (19 patients) Controls (38 patients) RA (38 patients)
LV End-diastolic diameter (ml/m2) 2.9 ± 0.3 2.3 ± 0.4 * 2.6 ± 0.3#
LV End-systolic diameter (ml/m 2) 1.9 ± 0.3 1.4 ± 0.4 * 1.7 ± 0.2#
LV End-diastolic volume (ml/m2) 66 ± 19 56 ± 12 51 ± 9 # §
LV End-systolic volume (ml/m2) 27 ± 9 21 ± 6 17 ± 4 # §
Relative wall thickness 0.35 ± 0.06 0.40 ± 0.07 * 0.43 ± 0.06 # §
Concentric LV geometry (%) 11 45 * 51 #
LV mass index (g/m 2.7) 41 ± 14 38 ± 13 38 ± 7#
LV hypertrophy (%) 37 20 * 6 # §
Inappropriate LV mass (%) 11 10 36 # §
LV stroke volume (ml) 73 ± 25 74 ± 18 59 ± 15 # §
Cardiac index (l/min/ m2) 2.7 ± 0.9 2.4 ± 0.7 2.3 ± 0.6#
LV ejection fraction (%) 60 ± 7 63 ± 5 65 ± 5#
LV CESS (dynes/cm2) 166 ± 49 128 ± 48 * 116 ± 28#
LV Sc- midwall shortening (%) 101 ± 15 98 ± 10 85 ± 11
Peak S’ (cm/sec) 7.1 ± 1.3 10.5 ± 3.6 * 10.2 ± 1.6#
Low peak S’ (%) 84 55 * 27# §
Peak E’ (cm/sec) 10.6 ± 3.5 12.3 ± 1.7 13.6 ± 2.2
E wave of transmitral flow (cm/sec) 103 ± 16 86 ± 19 * 75 ± 17# §
A wave of transmitral flow (cm/sec) 69 ± 25 64 ± 16 62 ± 15
E / A ratio 1.4 ± 0.36 1.4 ± 0.24 1.3 ± 0.40#
E / E’ ratio 10.5 ± 3.6 7.5 ± 2.3 * 5.6 ± 1.1# §
LV diastolic dysfunction (%) 11 2 * 3#
Maximal left atrial volume (ml/ m2) 27 ± 11 23 ± 11 18 ± 4
Aortic stiffness index (%) 9.8 ± 12.6 3.1 ± 2.0 * 4.8 ± 2.5#
Abnormally high aortic stiffness (% of patients) 26 10 21
CESS circumferential end-systolic stress, LV left ventricular; Peak E’early diastolic Tissue Doppler velocity of mitral annulus, Peak S’ peak mitral annular systolic
velocity (Tissue Doppler Imaging), RA rheumatoid arthritis, Sc stress corrected
* = p < 0.05 controls vs coarctation;
#= p < 0.05 rheumatoid arthritis vs coarctation;
§ = p < 0.05 rheumatoid arthritis vs controls
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age, sex, blood pressure and history of hypertension,
and the other one, affected by RA. Three main and
original findings emerged by our analyses: 1) AoSI was
significantly higher in CoA patients than in RA patients
or non-RA matched patients; 2) increased AoSI was
not homogeneous in CoA patients: two distinct groups,
indeed, were identified, the first including near a quarter
of subjects who had abnormally high values of AoSI, the
second including the remaining three quarter of subjects
who had values of AoSI in the normal range; 3) in CoA
patients, AoSI was independently related to LV hyper-
trophy and concentric LV geometry.
We previously demonstrated persistence of reduced
systolic LV long axis and diastolic functions in the long
run after successful repair of CoA. In addition, Lam et al.
showed that systolic LV long axis dysfunction was associ-
ated with increased AoSI in adult patients with corrected
CoA, independently from other potential confounders
such as hypertension and associated bicuspid aortic valve.
More recently, Voges et al. demonstrated a combination
Fig. 2 Distribution of AoSI between all groups. 5 CoA patients have exceptionally high AoSI
Fig. 1 Comparison of AoSI between CoA group, RA subjects and controls
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between the impairment of elastic properties in the thor-
acic aorta with the remodeling of the common carotid ar-
tery in young patients nearly fifteen years after CoA repair
[28]. Collectively, these findings suggest that CoA might
determine aortic wall changes as a systemic vessel disease
in humans. Using a clinically representative rabbit model
of CoA and correction, Menon et al. [29] quantified
mechanical alterations from a 20-mmHg blood pressure
gradient in the thoracic aorta and related the expression
of key smooth muscle contractile and focal adhesion pro-
teins with aortic remodeling, reduced relaxation and in-
creased stiffness. These structural and functional
changes were attributed to a significant increase in
non-muscle myosin and reduced smooth muscle myosin
heavy chain expression in the proximal arteries of CoA
which was not reversed upon blood pressure correction.
Furthermore, Gardiner et al. [30] found that, arterial dila-
tion induced by glyceryltrinitrate was significantly impaired
in the pre-coarctation vascular bed of young adults who
had undergone successful repair of coarctation in child-
hood. These results may be an important contributor to
rest and/or exercise-related hypertension and late morbidity
or mortality of these subjects.
Arterial stiffness and AoSI are independent predictors
of cardiovascular morbidity and mortality [9]. A number
of previous studies confirmed that non-invasive AoSI
had a strong correlation with invasive measurements of
arterial stiffness, and that the aortic elastic properties
deteriorate in patients with coronary artery disease
[10, 12]. Vitarelli et al. showed that the measurement
of AoSI allows to differentiate hypertensive from healthy
adults [11]. In addition, AoSI is increased in women with
a previous pregnancy complicated by early onset of
pre-eclampsia. Recently, Said et al. demonstrated that
AoSI measured by photofletmismography is an inde-
pendent predictor of cardiovascular events and mortality
in a UK large community-based population [9]. From the
analysis of our AoSI data, two different phenotypes of
repaired CoA patients emerged, corresponding to two
distinct pathophysiological models. CoA patients with
abnormally high AoSI, indeed, were largely different in
comparison with the counterparts with normal AoSI,
being older, with higher body mass index, blood pressure,
LV mass remodeled in a concentric fashion, and with
worse LV diastolic function. In these patients, greater LV
hypertrophy and relative wall thickness were possibly due
to the persistent LV pressure-overload. So, an older age at
the time of intervention seems to promote the develop-
ment of sky high AoSI more than nearly three decades of
follow up with well controlled blood pressure. In our
study, we compared LV properties and AoSI in CoA and
RA patients. Both diseases are characterized by a lower life
expectancy owing to premature CV diseases. RA is a
model of acquired extensive arterial disease with abnormal
vascular responses due to a number of cytotoxic agents,
pro-inflammatory and immuno-modulatory molecules and
hyper-functioning neuro-hormonal systems. In line with
previous experiences, RA patients had a prevalence of
abnormally high AoSI nearly two-fold higher than controls
Table 3 Variables significantly different between aortic coartaction patients who had abnormally high aortic stiffness and those who
had not
Total study population (19 patients) Abnormally high aortic stiffness NO (14 patients) Abnormally high aortic stiffness YES (5 patients) p
Age (years) 30 ± 10 43 ± 9 0.02
Body mass index (Kg/m2) 22.2 ± 2.7 27.7 ± 4.5 0.004
Systolic blood pressure (mmHg) 120 ± 14 144 ± 14 0.004
Diastolic blood pressure (mmHg) 73 ± 9 83 ± 10 0.04
E / E’ ratio 9.5 ± 2.1 13.7 ± 5.1 0.02
LV end-diastolic pressure (mmHg) 14 ± 3 19 ± 6 0.02
Relative wall thickness 0.33 ± 0.04 0.41 ± 0.04 0.002
LV mass index (g/m 2.7) 36 ± 13 56 ± 5 0.006
LV hypertrophy (%) 15 100 < 0.001
Aortic stiffness index (%) 2.5 ± 1.9 28.9 ± 6.5 < 0.001
E/E’ ratio = ratio between peak of early (E) wave of transmitral flow and peak (E’) early diastolic Tissue Doppler velocity of mitral annulus
Table 4 Variables significantly related to aortic stiffness index
(expressed as continuous variable): multiple linear regression
analysis
Standardized coefficients
beta
P
Left ventricular hypertrophy 0.62 < 0.001
Left ventricular relative wall
thickness
0.34 0.04
Final results multivariate
regression model
Intercept = − 25.0
Standard error of estimation = 6.9
r 2 = 0.74
0.86 < 0.001
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matched for the traditional CV risk factors. Although an
increased AoSI is a strong predictor of adverse clinical
outcome at mid-term follow-up, our RA subjects were less
treated with medications compared to CoA and controls.
This data is coherent with that derived by the EPIDAURO
registry showing the CV risk stratification missing in daily
clinical practice of RA patients [31]. CoA and RA repre-
sent different pathophysiological models of aortic disease.
The first one is an acquired structural damage primarily
caused by hemodynamic factors of longstanding distal
obstruction that lead to higher collagen load with a
lower elastin and smooth muscle content [32, 33]. The
second one is related to non-hemodynamic factors such
pro-inflammatory, immunomodulatory, and cytotoxic
agents that accelerate vascular atherosclerosis, myocardial
fibrosis, and apoptosis by way of direct damage of the
myocardial tissue. Despite these different models and
magnitude of AoSI, we found several common points. The
reduced long-term survival unites CoA and RA patients in
the follow up. Persistence or newly developed systemic
hypertension and AoSI may cause significant abnormalities
in the CV system of both diseases such as LV remodelling
and dysfunction, thereby compromising the prognosis.
Study limitations
This study has several limitations. Firstly, it was not
adequately powered to determine the effect of other
potential confounders (clinical significance of very mild
residual narrowing at CoA site, difference between surgical
or endovascular treatment approach and usage of antihy-
pertensive medications) on central aortic elastic properties.
Secondly, due to the small sample size of the study popula-
tion, we cannot draw any prognostic inference regarding
the detection of abnormally high AoSI condition. Further-
more, the evaluation of AoSI by central pulse pressure as
assessed by radial artery tonometry and pulse wave analysis
instead of the brachial artery pulse pressure might be
more accurate than M-mode-derived aortic recordings
and brachial blood pressure we used. Strengths of our
study include the very long-term follow-up, the consecutive
enrollment of patients, the reliable and appropriate method
utilized for the assessment of AoSI, and the comprehensive
nature of the dataset.
Conclusions
CoA patients have higher AoSI levels than RA patients
and non-RA matched controls. AoSI levels are abnormally
high in a small sub-group of CoA patients who show a
very high-risk clinical profile for adverse CV events.
Although CoA and RA represent two different patho-
physiological models of CV disease, they are characterized
by common detrimental consequences on LV function
and aortic properties. In CoA patients, intervention at an
early age before potentially irreversible structural changes
to proximal aorta, might be clinically relevant while in RA
patients, appropriate medical treatment to reduce AoSI,
might preserve LV geometry and function. These can only
be speculative conclusions: nonetheless, the results of this
study reinforce the importance of the notion that the
measurement of AoSI in CoA and RA patients should
conceivably be introduced into routine clinical practice.
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